XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Oct. 02, 2021
Sep. 26, 2020
Cash flows from operating activities:    
Net income $ 161,389,000 $ 169,633,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 26,449,000 21,200,000
Stock-based compensation 33,530,000 36,372,000
Loss on disposal of equipment, intangibles and other assets 371,000 202,000
Provision for credit losses 647,000 5,000
Provision for deferred income taxes 0 136,000
Changes in operating assets and liabilities:    
Increase in accounts receivable (50,967,000) (9,459,000)
Decrease (increase) in inventories 12,329,000 (86,815,000)
Decrease (increase) in other current assets 4,433,000 (23,461,000)
Increase in lease receivable, net (9,312,000) (6,279,000)
Increase in deferred costs and other contract assets (2,573,000) (1,964,000)
Increase in other non-current assets (144,000) (775,000)
(Decrease) increase in accounts payable (4,290,000) 31,793,000
(Decrease) increase in accrued compensation (1,298,000) 3,654,000
(Decrease) increase in accrued liabilities (3,969,000) 4,691,000
Decrease in income tax payable (1,456,000) (2,756,000)
Increase in deferred revenue and other contract-related liabilities 1,378,000 9,973,000
Increase in other non-current liabilities 634,000 395,000
Net cash provided by operating activities 167,151,000 146,545,000
Cash flows from investing activities:    
Maturities of short-term investments 0 (70,000,000)
Purchases of property and equipment, net (20,680,000) (60,017,000)
Increase in intangible assets (8,185,000) (5,763,000)
Business combinations, net of cash acquired 0 78,310,000
Other strategic investing activities (2,600,000) (6,750,000)
Net cash used in investing activities (31,465,000) (80,840,000)
Cash flows from financing activities:    
Proceeds from issuance of common stock 18,975,000 40,994,000
Payroll tax withholdings on behalf of employees for vested equity awards (16,724,000) (1,449,000)
Repurchases of common stock (128,917,000) (591,000)
Net cash (used in) provided by financing activities (126,666,000) 38,954,000
Effect of foreign currency exchange rates on cash (89,000) (294,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8,931,000 104,365,000
Cash, cash equivalents and restricted cash at end of period 652,354,000 669,056,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 653,935,000 $ 672,440,000